Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00606918 · ClinicalTrials.gov registry record
Validation of a New Device to Measure Neuromuscular Disease Progression
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 120
- Enrollment target
NCT00606918: Completed study, sponsored by Massachusetts General Hospital.
NCT00606918 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00606918 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
There is a great need for the development of sensitive outcomes that allow experimental drugs to be tested in human subjects more efficiently. If we could more precisely measure whether an experimental drug slows the progression of ALS or other neuromuscular diseases, this would allow more drugs to be tested quicker and at less expense. We have developed a new device that accurately measures isometric strength called: Accurate Test of Limb Isometric Strength (ATLIS). This device was designed to be portable, quick, and easy to use, while generating accurate and reliable, interval level data. This study will enable us to test the reliability and validity of ATLIS.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00606918
The ClinicalTrials.gov registry entry for NCT00606918 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00606918 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00606918 about?
NCT00606918 is a clinical study titled "Validation of a New Device to Measure Neuromuscular Disease Progression". There is a great need for the development of sensitive outcomes that allow experimental drugs to be tested in human subjects more efficiently. If we could more precisely measure whether an experimental drug slows the progression of ALS or other neuromuscular diseases, this would allow more drugs to ...
What is the current status of trial NCT00606918?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2008-01. Estimated completion is 2010-09.
Who is sponsoring clinical trial NCT00606918?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.